Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Kidney Neoplasms 1

Interventions

Nivolumab 4cabozantinib 2Sodium Chloride 2Saline Solution 2Everolimus 2Anesthesia, Epidural 2polyethylene glycol 3350 1aldesleukin 1Tobacco Use Cessation Devices 1Standard of Care 1Solutions 1Sevoflurane 1Radiotherapy 1Psychiatric Rehabilitation 1Propofol 1Polymerase Chain Reaction 1Papaverine 1Nutrition Therapy 1Neuroleptanalgesia 1Lidocaine 1Ipilimumab 1Intubation 1Hydroxyethyl Starch Derivatives 1HES 130-0.4 1Glucose 1Gene Expression Profiling 1Fentanyl 1Early Intervention, Educational 1Dexmedetomidine 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Kidney Neoplasms × Papaverine × Clear all
NCT04162834 2021-04-19

Effect of Papaverine on Renal Artery Blood Flow Volume

Asan Medical Center

Phase 4 Completed
96 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡